Pdl Biopharma Inc (PDLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Sales | 344,975 | 318,184 | 294,196 | 225,085 | 187,343 |
| Gross Profit | 344,975 | 318,184 | 294,196 | 225,085 | 187,343 |
| Operating Expenses | 133,896 | 21,064 | 51,544 | 41,176 | 31,881 |
| Operating Income | 211,079 | 297,120 | 242,652 | 183,909 | 155,462 |
| Interest Expense | 43,529 | 19,357 | 14,219 | 13,069 | 12,519 |
| Other Income | -17,180 | 2,522 | 14,901 | 20,233 | 16,967 |
| Pre-tax Income | 150,370 | 280,285 | 243,334 | 191,073 | 159,910 |
| Income Tax | 58,496 | 90,625 | 5,014 | 10,624 | 3,199 |
| Net Income Continuous | 91,874 | 189,660 | 238,320 | 180,449 | 156,711 |
| Net Income Discontinuous | N/A | N/A | -169,933 | -201,510 | -286,731 |
| Net Income | $91,874 | $189,660 | $68,387 | $-21,061 | $-130,020 |
| EPS Basic Total Ops | 0.73 | 1.59 | 0.58 | -0.18 | -1.14 |
| EPS Basic Continuous Ops | 0.73 | 1.59 | 2.01 | 1.55 | 1.38 |
| EPS Basic Discontinuous Ops | N/A | N/A | -1.43 | -1.73 | -2.52 |
| EPS Diluted Total Ops | 0.54 | 1.07 | 0.47 | -0.18 | -0.84 |
| EPS Diluted Continuous Ops | 0.51 | 1.03 | 1.48 | 1.55 | 1.20 |
| EPS Diluted Discontinuous Ops | N/A | N/A | -1.01 | -1.73 | -2.04 |
| EBITDA(a) | $220,329 | $301,526 | $267,491 | $250,744 | $233,477 |